{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:29:17Z","timestamp":1761863357064,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ajo.2025.03.038","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T02:40:57Z","timestamp":1743129657000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Short-Term Treatment of Syphilitic Uveitis With Intravitreal Ceftazidime"],"prefix":"10.1016","volume":"276","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5077-3587","authenticated-orcid":false,"given":"Emily C.","family":"Davis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0419-4039","authenticated-orcid":false,"given":"Akshay S.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10398","key":"10.1016\/j.ajo.2025.03.038_bib0001","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0140-6736(22)02348-0","article-title":"Syphilis","volume":"402","author":"Peeling","year":"2023","journal-title":"The Lancet"},{"key":"10.1016\/j.ajo.2025.03.038_bib0002","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6594849","article-title":"Clinical features and treatments of syphilitic uveitis: a systematic review and meta-analysis","volume":"2017","author":"Zhang","year":"2017","journal-title":"J Ophthalmol"},{"year":"2023","author":"Koundanya","series-title":"Syphilis Ocular Manifestations","key":"10.1016\/j.ajo.2025.03.038_bib0003"},{"issue":"4","key":"10.1016\/j.ajo.2025.03.038_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections Treatment Guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"year":"2016","article-title":"Recommendations for treatment of syphilis","series-title":"WHO Guidelines for the Treatment of Treponema pallidum (Syphilis)","key":"10.1016\/j.ajo.2025.03.038_bib0005"},{"issue":"1","key":"10.1016\/j.ajo.2025.03.038_bib0006","article-title":"Evaluating the global, regional, and national impact of syphilis: results from the global burden of disease study 2019","volume":"13","author":"Chen","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajo.2025.03.038_bib0007","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1017\/S0950268819000281","article-title":"The resurgence of syphilis in high-income countries in the 2000s: a focus on Europe","volume":"147","author":"Spiteri","year":"2019","journal-title":"Epidemiol Infect"},{"unstructured":"CDC. Syphilis Surveillance Supplement 2013-2017. U.S. Centers for Disease Control (CDC). https:\/\/www.cdc.gov\/std\/statistics\/syphilis-supplement\/default.htm. Accessed April 22, 2025.","key":"10.1016\/j.ajo.2025.03.038_bib0008"},{"issue":"10401","key":"10.1016\/j.ajo.2025.03.038_bib0009","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0140-6736(23)01665-3","article-title":"Syphilis rates soar in the USA amid penicillin shortage","volume":"402","author":"Nelson","year":"2023","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ajo.2025.03.038_bib0010","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jamadermatol.2022.3499","article-title":"Resurgence of syphilis in the US-USPSTF reaffirms screening guidelines","volume":"158","author":"Amerson","year":"2022","journal-title":"JAMA Dermatol"},{"unstructured":"Sweeney C. Surge in syphilis cases leads some providers to ration penicillin. KFF Health News. https:\/\/kffhealthnews.org\/news\/article\/syphilis-penicillin-rationing-shortage-amoxicillin-doxycycline\/. Accessed November 20, 2024.","key":"10.1016\/j.ajo.2025.03.038_bib0011"},{"issue":"1","key":"10.1016\/j.ajo.2025.03.038_bib0012","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/09273948.2017.1385817","article-title":"Combined intravitreal and systemic antibiotic therapy in a patient with syphilitic uveitis","volume":"27","author":"Sood","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"issue":"10","key":"10.1016\/j.ajo.2025.03.038_bib0013","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1177\/09564624211011917","article-title":"A case series with literature review on adjunctive usage of intravitreal ceftazidime in ocular syphilis with human immunodeficiency virus infection","volume":"32","author":"Lim","year":"2021","journal-title":"Int J STD AIDS"},{"issue":"3","key":"10.1016\/j.ajo.2025.03.038_bib0014","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.03.038_bib0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1001\/jamaophthalmol.2023.5386","article-title":"Rising incidence of syphilitic uveitis-related hospitalizations in the US","volume":"142","author":"Mir","year":"2024","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2025.03.038_bib0016","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/jac\/dkab100","article-title":"Clinical and serological outcomes in patients treated with oral doxycycline for early neurosyphilis","volume":"76","author":"Girometti","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.ajo.2025.03.038_bib0017","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1093\/jac\/dky102","article-title":"Oral doxycycline for syphilitic uveitis: a case report highlighting potential efficacy","volume":"73","author":"Amode","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.ajo.2025.03.038_bib0018","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-020-00241-2","article-title":"Health care for homeless people","volume":"7","author":"Liu","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"10.1016\/j.ajo.2025.03.038_bib0019","doi-asserted-by":"crossref","first-page":"e994","DOI":"10.1016\/S2666-5247(23)00219-7","article-title":"Antimicrobial susceptibility of Treponema pallidum subspecies pallidum: an in-vitro study","volume":"4","author":"Tantalo","year":"2023","journal-title":"Lancet Microbe"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425001552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425001552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T12:53:38Z","timestamp":1751979218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939425001552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":19,"alternative-id":["S0002939425001552"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2025.03.038","relation":{},"ISSN":["0002-9394"],"issn-type":[{"type":"print","value":"0002-9394"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-Term Treatment of Syphilitic Uveitis With Intravitreal Ceftazidime","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2025.03.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}